Tarsus Pharmaceuticals Stock Price History
| TARS Stock | USD 50.22 2.01 3.85% |
Below is the normalized historical share price chart for Tarsus Pharmaceuticals extending back to October 16, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Tarsus Pharmaceuticals stands at 50.22, as last reported on the 16th of February 2025, with the highest price reaching 52.52 and the lowest price hitting 50.01 during the day.
If you're considering investing in Tarsus Stock, it is important to understand the factors that can impact its price. Tarsus Pharmaceuticals appears to be very steady, given 3 months investment horizon. Tarsus Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0803, which indicates the firm had a 0.0803 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Tarsus Pharmaceuticals, which you can use to evaluate the volatility of the company. Please review Tarsus Pharmaceuticals' Coefficient Of Variation of 4355.55, risk adjusted performance of 0.0238, and Semi Deviation of 3.06 to confirm if our risk estimates are consistent with your expectations.
At this time, Tarsus Pharmaceuticals' Other Stockholder Equity is comparatively stable compared to the past year. Stock Based Compensation is likely to gain to about 23.9 M in 2025, whereas Common Stock Total Equity is likely to drop 3,520 in 2025. . At this time, Tarsus Pharmaceuticals' Price To Sales Ratio is comparatively stable compared to the past year. Price Book Value Ratio is likely to gain to 2.85 in 2025, despite the fact that Price Earnings To Growth Ratio is likely to grow to (0.06). Tarsus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of October 2020 | 200 Day MA 38.2267 | 50 Day MA 51.9294 | Beta 1.014 |
Tarsus |
Sharpe Ratio = 0.0803
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TARS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.95 actual daily | 26 74% of assets are more volatile |
Expected Return
| 0.24 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Tarsus Pharmaceuticals is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tarsus Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 8.0837 | Enterprise Value Ebitda (3.23) | Price Sales 14.8105 | Shares Float 29 M | Wall Street Target Price 67.5556 |
Tarsus Pharmaceuticals Stock Price History Chart
There are several ways to analyze Tarsus Stock price data. The simplest method is using a basic Tarsus candlestick price chart, which shows Tarsus Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 5, 2025 | 56.94 |
| Lowest Price | January 14, 2025 | 44.33 |
Tarsus Pharmaceuticals February 16, 2025 Stock Price Synopsis
Various analyses of Tarsus Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Tarsus Stock. It can be used to describe the percentage change in the price of Tarsus Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Tarsus Stock.| Tarsus Pharmaceuticals Price Rate Of Daily Change | 0.96 | |
| Tarsus Pharmaceuticals Price Action Indicator | (2.05) | |
| Tarsus Pharmaceuticals Price Daily Balance Of Power | (0.80) |
Tarsus Pharmaceuticals February 16, 2025 Stock Price Analysis
Tarsus Stock Price History Data
The price series of Tarsus Pharmaceuticals for the period between Mon, Nov 18, 2024 and Sun, Feb 16, 2025 has a statistical range of 12.61 with a coefficient of variation of 6.21. The price distribution for the period has arithmetic mean of 50.98. The median price for the last 90 days is 51.64.| Open | High | Low | Close | Volume | ||
02/16/2025 | 52.36 | 52.52 | 50.01 | 50.22 | ||
| 02/14/2025 | 52.36 | 52.52 | 50.01 | 50.22 | 315,387 | |
| 02/13/2025 | 52.75 | 53.22 | 51.09 | 52.23 | 439,489 | |
| 02/12/2025 | 50.65 | 52.97 | 50.65 | 52.33 | 460,920 | |
| 02/11/2025 | 51.47 | 52.01 | 49.86 | 51.22 | 515,071 | |
| 02/10/2025 | 53.33 | 53.56 | 50.95 | 51.76 | 543,627 | |
| 02/07/2025 | 53.32 | 54.28 | 51.35 | 52.95 | 620,699 | |
| 02/06/2025 | 56.57 | 56.96 | 52.57 | 53.32 | 587,257 | |
| 02/05/2025 | 54.89 | 57.28 | 54.89 | 56.94 | 421,759 | |
| 02/04/2025 | 54.71 | 55.98 | 54.21 | 54.50 | 310,379 | |
| 02/03/2025 | 52.47 | 56.21 | 52.08 | 54.14 | 399,764 | |
| 01/31/2025 | 52.25 | 54.53 | 51.84 | 53.76 | 372,733 | |
| 01/30/2025 | 53.25 | 53.77 | 51.30 | 51.74 | 509,944 | |
| 01/29/2025 | 50.87 | 53.44 | 50.30 | 53.07 | 366,904 | |
| 01/28/2025 | 51.50 | 51.67 | 50.05 | 51.06 | 328,450 | |
| 01/27/2025 | 48.69 | 54.08 | 48.20 | 51.45 | 712,576 | |
| 01/24/2025 | 49.30 | 50.20 | 48.08 | 48.78 | 464,400 | |
| 01/23/2025 | 47.89 | 50.02 | 47.55 | 49.12 | 579,865 | |
| 01/22/2025 | 46.73 | 48.34 | 46.38 | 48.11 | 458,491 | |
| 01/21/2025 | 46.96 | 48.00 | 45.72 | 46.74 | 551,245 | |
| 01/17/2025 | 47.29 | 47.54 | 46.05 | 46.52 | 357,670 | |
| 01/16/2025 | 46.50 | 47.25 | 45.61 | 46.92 | 437,805 | |
| 01/15/2025 | 45.75 | 46.69 | 44.40 | 46.56 | 938,163 | |
| 01/14/2025 | 47.82 | 47.87 | 43.61 | 44.33 | 1,060,243 | |
| 01/13/2025 | 49.97 | 50.70 | 45.76 | 47.02 | 1,249,653 | |
| 01/10/2025 | 54.05 | 54.38 | 51.94 | 52.69 | 807,895 | |
| 01/08/2025 | 54.79 | 55.95 | 53.31 | 55.24 | 904,964 | |
| 01/07/2025 | 56.50 | 57.00 | 52.69 | 55.08 | 890,708 | |
| 01/06/2025 | 55.99 | 56.85 | 54.89 | 56.20 | 1,829,374 | |
| 01/03/2025 | 55.14 | 56.02 | 54.18 | 55.67 | 584,940 | |
| 01/02/2025 | 55.91 | 57.14 | 54.53 | 55.15 | 834,217 | |
| 12/31/2024 | 55.04 | 56.31 | 54.52 | 55.37 | 742,027 | |
| 12/30/2024 | 54.69 | 57.14 | 53.51 | 54.70 | 506,643 | |
| 12/27/2024 | 54.13 | 55.22 | 53.86 | 55.00 | 478,975 | |
| 12/26/2024 | 53.80 | 55.01 | 53.01 | 54.35 | 273,685 | |
| 12/24/2024 | 54.88 | 54.88 | 53.66 | 54.04 | 128,793 | |
| 12/23/2024 | 52.73 | 54.61 | 51.62 | 54.41 | 431,966 | |
| 12/20/2024 | 50.52 | 53.62 | 50.20 | 52.91 | 816,369 | |
| 12/19/2024 | 52.92 | 53.50 | 50.54 | 52.00 | 580,288 | |
| 12/18/2024 | 53.61 | 56.77 | 51.84 | 52.70 | 850,169 | |
| 12/17/2024 | 51.61 | 53.54 | 51.08 | 53.26 | 528,715 | |
| 12/16/2024 | 52.64 | 53.85 | 51.23 | 51.73 | 473,617 | |
| 12/13/2024 | 49.20 | 52.99 | 48.45 | 52.50 | 674,505 | |
| 12/12/2024 | 51.59 | 52.67 | 49.70 | 51.08 | 747,057 | |
| 12/11/2024 | 51.25 | 54.44 | 50.49 | 52.14 | 436,561 | |
| 12/10/2024 | 50.59 | 51.58 | 50.19 | 50.65 | 763,368 | |
| 12/09/2024 | 51.64 | 51.89 | 49.35 | 50.66 | 299,870 | |
| 12/06/2024 | 50.80 | 52.02 | 49.99 | 51.79 | 335,487 | |
| 12/05/2024 | 51.58 | 51.73 | 50.27 | 50.32 | 295,792 | |
| 12/04/2024 | 50.54 | 52.13 | 50.11 | 51.64 | 333,386 | |
| 12/03/2024 | 50.18 | 51.02 | 49.65 | 50.40 | 634,292 | |
| 12/02/2024 | 52.49 | 52.78 | 49.82 | 50.42 | 604,459 | |
| 11/29/2024 | 50.99 | 52.65 | 50.88 | 52.45 | 290,714 | |
| 11/27/2024 | 49.98 | 51.46 | 49.95 | 50.84 | 486,401 | |
| 11/26/2024 | 48.35 | 51.25 | 48.06 | 49.66 | 549,397 | |
| 11/25/2024 | 48.77 | 49.09 | 47.63 | 48.32 | 522,284 | |
| 11/22/2024 | 46.63 | 48.50 | 45.98 | 48.24 | 589,206 | |
| 11/21/2024 | 46.86 | 47.60 | 45.19 | 46.40 | 445,178 | |
| 11/20/2024 | 46.90 | 47.37 | 45.73 | 46.58 | 356,384 | |
| 11/19/2024 | 44.06 | 46.90 | 44.00 | 46.89 | 431,267 | |
| 11/18/2024 | 44.89 | 46.79 | 44.27 | 44.63 | 817,291 |
About Tarsus Pharmaceuticals Stock history
Tarsus Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Tarsus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Tarsus Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Tarsus Pharmaceuticals stock prices may prove useful in developing a viable investing in Tarsus Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 33.8 M | 21.8 M | |
| Net Loss | -55.9 M | -53.1 M |
Tarsus Pharmaceuticals Quarterly Net Working Capital |
|
Tarsus Pharmaceuticals Stock Technical Analysis
Tarsus Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Stock Tickers Now
Stock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
| All Next | Launch Module |
Tarsus Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Tarsus Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Tarsus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Tarsus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0238 | |||
| Jensen Alpha | 0.0569 | |||
| Total Risk Alpha | 0.0526 | |||
| Sortino Ratio | 0.018 | |||
| Treynor Ratio | 0.2323 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Tarsus Stock Analysis
When running Tarsus Pharmaceuticals' price analysis, check to measure Tarsus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tarsus Pharmaceuticals is operating at the current time. Most of Tarsus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tarsus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tarsus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tarsus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.